Sativex, MS cannabis drug yet to take off
Posted: Mon Nov 08, 2010 12:39 am
GW Pharmaceuticals' pioneering cannabis drug is getting a mixed reception four months into its launch across Britain, its first European market.
A survey of primary care trusts today found several that were not recommending Savitex to multiple sclerosis patients, with many viewing it as “low priority”.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814